March 2023 — Pharma News Archive

Every regulatory action (115), Phase 3 readout (0), and patent expiry (12) tracked in March 2023. Sourced from Drugs@FDA, EMA EPAR, ClinicalTrials.gov, USPTO Orange Book.

115 regulatory actions 0 Phase 3 readouts 12 patent expiries

Regulatory actions (115)

Phase 3 trial readouts (0)

No Phase 3 readouts tracked in this month.

Patent expiries (12)

Subscribe to ongoing alerts

This page is a permanent monthly archive. For ongoing alerts as new events happen:

See also